Choose Your Condition

Crohn’s Disease Ulcerative Colitis

Discover the only gut-focused
treatment^* for Crohn’s and UC
that works right where U need it

Choose Your Condition

Crohn’s Disease Ulcerative Colitis

^*ENTYVIO helps block certain inflammation-causing cells from entering the gut.

#1 prescribed biologic for Crohn's and ulcerative colitis combined†.

^†Quarterly analysis of claims data from June 2022–September 2024.

Focus
U Want

Helps block inflammation
right where it occurs:
In your gut

*ENTYVIO helps block certain inflammation-causing cells from entering the gut

How ENTYVIO Works

Results
U Need

Lasting relief and
steroid-free remission
at 1 year^‡

Some people experienced rapid symptom relief as early as 6 weeks^‡

Individual results may vary.

Crohn’s Results UC Results

^‡Many patients taking ENTYVIO IV achieved remission at Week 52, some without steroids. Some achieved remission at Week 6. Remission is a measure to determine when a patient with Crohn’s or UC is experiencing few to no symptoms and an improvement in their condition.

Experience
U Expect

More than 10 years of patient experience

2 options for therapy: ENTYVIO IV and the ENTYVIO Pen^§

^§After at least 2 IV starter doses.

Explore Your Options

IV=intravenous.

Support
U Deserve

Eligible ENTYVIO patients may pay as little as $5 per dose

Growing coverage for
the ENTYVIO Pen^¶

1-on-1 support through EntyvioConnect for people prescribed ENTYVIO

Get Support

^¶Coverage of the ENTYVIO Pen as of January 2025.

What is ENTYVIO?

ENTYVIO (vedolizumab) is a biologic used to treat Crohn’s disease and ulcerative colitis when certain other medicines haven’t worked well enough or could not be tolerated. Doctors have prescribed ENTYVIO for over 10 years.

With ENTYVIO, there are options

ENTYVIO can be administered 2 different ways, by IV infusion or by a self-administered injection, also known as the ENTYVIO Pen. After at least 2 IV doses, you can use the ENTYVIO Pen at home or on the go.

Real stories from ENTYVIO patients

Everybody’s journey to treatment with ENTYVIO is different. Hear from other people living with Crohn’s and UC share their struggles, their successes, and how ENTYVIO has helped them.

“I was on lots of different medications for about 8 years, up and down, just going from one flare to the next. So I went and talked to my doctor, and he recommended ENTYVIO.”

Sheila, real patient living with Crohn’s

Watch their stories

Supporting you from the start

Cost shouldn't be a barrier for treatment. If you've been prescribed ENTYVIO, get co-pay support for your prescription with EntyvioConnect. Plus, get one-on-one nurse support.

*Must meet eligibility requirements.

Learn about support options

*Must meet eligibility requirements.

IMPORTANT SAFETY INFORMATION

Do not receive ENTYVIO^® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before receiving and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have tuberculosis (TB) or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.

Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.

ENTYVIO is available for:

intravenous (IV) infusion: 300 mg vedolizumab.
subcutaneous (SC) injection: 108 mg vedolizumab.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

What is ENTYVIO (vedolizumab)?

ENTYVIO is a prescription medicine used in adults for the treatment of:

moderately to severely active ulcerative colitis (UC).
moderately to severely active Crohn’s disease (CD).

It is not known if ENTYVIO is safe and effective in children under 18 years of age.

Important Safety Information

Do not receive ENTYVIO^® if you have had an allergic reaction to ENTYVIO or any of its ingredients.

ENTYVIO may cause serious side effects, including:

Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
Infections. ENTYVIO may increase your risk of getting a serious infection. Before receiving and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination.
Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).

The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.

Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have tuberculosis (TB) or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.

Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.

ENTYVIO is available for:

intravenous (IV) infusion: 300 mg vedolizumab.

subcutaneous (SC) injection: 108 mg vedolizumab.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

What is ENTYVIO (vedolizumab)?

ENTYVIO is a prescription medicine used in adults for the treatment of:

moderately to severely active ulcerative colitis (UC).

moderately to severely active Crohn’s disease (CD).

It is not known if ENTYVIO is safe and effective in children under 18 years of age.

Discover the only gut-focused treatment* for Crohn’s and UCthat works right where U need it

What is ENTYVIO?

With ENTYVIO, there are options

Real stories from ENTYVIO patients

Supporting you from the start

You are About to Leave this Website and Enter a Website Operated by an Independent Third Party

You are about to leave this website.

Share with Your Friends and Family:

Discover the only gut-focused
treatment^* for Crohn’s and UC
that works right where U need it